- Report
- March 2025
- 384 Pages
Global
From €4692EUR$4,950USD£3,920GBP
- Report
- November 2023
- 55 Pages
Global
From €2370EUR$2,500USD£1,980GBP
- Report
- July 2021
- 43 Pages
Global
From €2370EUR$2,500USD£1,980GBP
- Report
- July 2021
- 33 Pages
Global
From €2370EUR$2,500USD£1,980GBP
- Report
- November 2024
- 96 Pages
Global
From €3500EUR$3,956USD£3,026GBP
The Implantable Drug Delivery System (IDDS) market is a subset of the Infusions and Injectables market. IDDS are medical devices used to deliver drugs directly into the body over a period of time. These devices are typically implanted under the skin and can be used to treat a variety of chronic conditions, such as diabetes, cancer, and cardiovascular diseases. IDDS are designed to provide a more consistent and controlled release of medication than traditional methods, such as oral or injectable drugs.
IDDS are becoming increasingly popular due to their ability to provide long-term drug delivery with fewer side effects. They are also more cost-effective than traditional methods, as they require fewer visits to the doctor and fewer doses of medication.
Some of the major players in the IDDS market include Medtronic, Johnson & Johnson, Becton Dickinson, and Baxter International. These companies are leading the way in developing innovative IDDS technologies and products. Show Less Read more